Reimbursement analysis and strategy in Europe
We will help you navigate through the challenges of reimbursement and funding for medical devices and in-vitro diagnostics in Europe
MTRC is a provider of on-demand and off-the-shelf European reimbursement analysis and strategy for industry and investment companies
We have specific offers tailored for different types of customers. Please proceed with our specific sub-sites to find out more
News and blog posts
Stay up-to-date about developments of reimbursement systems in Europe
11 Apr 2018
Eight reimbursement reports with the total size of 882 pages cover the most common radiotherapy modalities including brachytherapy, 3D conformal radiation therapy, stereotactic radiosurgery, stereotactic body radiation therapy, intensity-modulated radiotherapy (IMRT), volumetric modulated arc therapy (VMAT), image-guided radiotherapy, proton therapy. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 12 EU countries including Austria, Belgium, Denmark, England, Finland, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland.
25
Apr 2018
In April 2018, Oleg Borisenko with support from the MTRC launched an international stipend and mentoring program. The objective of the program is to support medical students in developing countries with achieving maximum results in a medical profession. For the first round of the program (six months until Oct 2018), three students were selected. The program includes a stipend, bi-weekly meetings on different subjects (goal setting, evidence-based medicine, clinical epidemiology, medical experiment, marketing, publication standards and others) and a personal mentoring of Oleg Borisenko.
25
Apr 2018
In the first half of April, the National Institute for Health and Care Excellence (NICE) published one new medtech innovation briefing for device that usesroutinely available datasets to help identify people who are at high risk of developing colorectal cancer.
The Norwegian Directorate of Health has published the annual report on drivers and trends in eHealth
24
Apr 2018
The report “Development Trend 2018” will help to provide a basis for analyzing the environment for eHealth and creating a frame of reference for understanding the eHealth development.
23
Apr 2018
In February of 2018, Dental and Pharmaceutical Benefit Agency (Tandvårds- och läkemedelsförmånsverket, TLV) has published a number of consumable medical devices, which were excluded from the list of pharmaceutical benefits per manufacturers’ request.
About us
|
We are a group of enthusiasts who are passionate about the areas of health policy, evidence generation, reimbursement and funding for medical technologies. We have turned our passion into a career. More specifically, we develop insights which help our customers optimize their business decisions Our company is based in Stockholm, Sweden |
The founder of company is Oleg Borisenko, one of the leading experts on European market access for medical devices. With more than 12 years of experience in the field, Oleg has led several hundred of projects. These include reimbursement analyses and strategies, value dossiers, health economic models and evidence generation strategies Our team consists of eight clinical coders and market analysts, including five medical doctors and one pharmacist. Three of our members have PhD degrees in different areas of clinical and public health science |
Our unique proposition is Pan-European reimbursement mapping and strategy projects for the Med Tech and IVD industries. To match the requirements and budget of our various customers, we approach their needs differently: from low-cost off-the-shelf reimbursement reports for dozens of medical technologies to full scale reimbursement and evidence generation projects We provide analyses for 14 European countries |
Check out our database of the off-the-shelf reimbursement reports for medical technologies in 11 European countries
Released reports:
|
Ongoing reports:
|